OraSure Technologies Equity 2024

OraSure Technologies Aktienanalyse

What does OraSure Technologies do?

OraSure Technologies Inc. is a US company specializing in the development, manufacturing, and marketing of diagnostic medical products. It was founded in 1987 under the name SolarCare Technologies Corporation and changed its name to OraSure Technologies Inc. in 2000. The company's main goal is to reduce the prevalence of infectious diseases and improve global health. It focuses on four core areas: infectious diseases, microfluidic analysis, application management, and genomics. In the field of infectious diseases, OraSure Technologies Inc. produces various rapid tests for detecting diseases such as HIV, Hepatitis C, and Syphilis. It also offers tests for drug and alcohol consumption verification. In microfluidic analysis, the company produces devices and test kits for biomedical research and clinical use. These technologies allow for the quick analysis of small samples and accurate results. Application management is another important aspect of the company, offering cloud-based applications for optimized data and information management. These applications help businesses and institutions obtain real-time data and use data analytics tools. Additionally, OraSure Technologies Inc. is involved in genomics and offers various products and services related to DNA sequencing. The company has a broad customer base, ranging from government agencies and research institutions to service companies and private clinics. It operates in numerous countries worldwide. An example of a product from OraSure Technologies is the OraQuick HIV self-test, which allows individuals to determine within 20 minutes whether they are infected with the HIV virus or not. This is particularly important for people who cannot or do not want to visit a doctor and value their privacy. OraSure Technologies' history is marked by numerous innovations and significant milestones. One notable event was the development of the first oral HIV rapid test in 2004, which allowed for quick and reliable detection of the virus through a saliva sample instead of a blood sample. In recent years, the company has increased its investment in research and development and formed partnerships with companies and institutions to bring innovative diagnostic medical products to the market. In summary, OraSure Technologies Inc. is a leading US company specializing in the development, manufacturing, and marketing of diagnostic medical products. With a focus on infectious diseases, microfluidic analysis, application management, and genomics, the company has a wide range of products and a broad customer base. OraSure Technologies is an innovative company striving to improve global health through partnerships and investments in research and development. OraSure Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing OraSure Technologies's Equity

OraSure Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding OraSure Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating OraSure Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

OraSure Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in OraSure Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about OraSure Technologies Stock

What is the equity of OraSure Technologies this year?

OraSure Technologies has equity of 430.67 M USD this year.

What was the equity of OraSure Technologies compared to the previous year?

The equity of OraSure Technologies has increased/decreased by 18.19% increased compared to the previous year.

What impact does a high equity have on investors of OraSure Technologies?

A high equity is advantageous for investors of OraSure Technologies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of OraSure Technologies?

A low equity can be a risk for investors of OraSure Technologies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of OraSure Technologies affect the company?

An increase in equity of OraSure Technologies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of OraSure Technologies affect the company?

A reduction in equity of OraSure Technologies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of OraSure Technologies?

Some factors that can affect the equity of OraSure Technologies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of OraSure Technologies so important for investors?

The equity of OraSure Technologies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can OraSure Technologies take to change the equity?

To change equity, OraSure Technologies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does OraSure Technologies pay?

Over the past 12 months, OraSure Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OraSure Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of OraSure Technologies?

The current dividend yield of OraSure Technologies is .

When does OraSure Technologies pay dividends?

OraSure Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OraSure Technologies?

OraSure Technologies paid dividends every year for the past 0 years.

What is the dividend of OraSure Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OraSure Technologies located?

OraSure Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von OraSure Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OraSure Technologies from 6/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.

When did OraSure Technologies pay the last dividend?

The last dividend was paid out on 6/20/2024.

What was the dividend of OraSure Technologies in the year 2023?

In the year 2023, OraSure Technologies distributed 0 USD as dividends.

In which currency does OraSure Technologies pay out the dividend?

The dividends of OraSure Technologies are distributed in USD.